|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/60 | |
| A61K 45/06 | |||
| A61P 39/00 | |||
| C07D 489/04 |
| (11) | Number of the document | 2992903 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15188944.1 |
| Date of filing the European patent application | 2011-09-29 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 388501 P | 2010-09-30 | US |
| (72) |
ASLUND, Bengt Leonard, SE
AURELL, Carl-Johan, SE
BOHLIN, Martin Hans, SE
SEBHATU, Tesfai, SE
YMEN, Bo Ingvar, SE
HEALY, Eric Thomas, US
JENSEN, David Richard, US
JONAITIS, David Thomas, US
PARENT, Stephan, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
Nektar Therapeutics, 455 Mission Bay Boulevard Suite 100, San Francisco, CA 94158, US |
| (54) | COMBINATION OF A NALOXOL-PEG CONJUGATE AND AN OPIOID AGONIST |
| COMBINATION OF A NALOXOL-PEG CONJUGATE AND AN OPIOID AGONIST |